Research and Development

Showing 15 posts of 9607 posts found.

opioid_pills

Prescription painkillers reclassified amid addiction concerns

October 17, 2018 Research and Development UK, addiction, classification, painkillers, policy

Two commonly prescribed painkillers are set to be put under tighter controls in the United Kingdom after a number of …
merckwindow_web

MSD and Samsung Bioepis terminate development of Lantus biosimilar for diabetes

October 15, 2018 Research and Development, Sales and Marketing Lantus, MSD, Samsung Bioepis, Sanofi, biosimilar, diabetes, pharma

MSD has reportedly terminated a previous agreement with Samsung Bioepis which would have seen them collaborate on a biosimilar version …
ai_robot

AI, big data: Making a case for faster drug discovery

October 15, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing AI, Big Data, feature, healthcare, research

They’re two of the biggest buzzwords getting professionals excited across pharma – Anjali Shukla explores the ways in which AI …

BMS’ Opdivo fails to improve overall survival in small-cell lung cancer

October 15, 2018 Research and Development, Sales and Marketing BMS< Opdivo, Bristol-Myers Squibb, Cancer, lung cancer, pharma

Bristol-Myers Squibb’s Opdivo (nivolumab) failed to deliver on its primary endpoint in a Phase 3 study in small-cell lung cancer, …
novo_flag

Novo Nordisk’s Fiasp shows strong blood sugar control in under-18 type 1 diabetes patients

October 12, 2018 Medical Communications, Research and Development Fiasp, Novo Nordisk, Type 1 diabetes, diabetes, pharma

New data unveiled by Novo Nordisk has shown that its insulin injection Fiasp (fast-acting insulin aspart) could provide a better …
top_10_image

Top Ten most popular articles on Pharmafile.com this week

October 12, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing WHO, biosimilars. GSK, manufacturing, pharma, top 10

Politics played a big role in pharma this week after Trump introduced legislation aimed at reducing the price of drugs. …

Living with Langerhans Cell Histiocytosis

October 11, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Langerhans Cell Histiocytosis, feature. pharma, patient experience, rare diseae

Affected as a young child by a rare disease which targets just one in 200,000 and led to neurodegeneration throughout …
roche__tree

Roche’s Ocrevus shows earlier, better outcomes in primary progressive and relapsing MS

October 11, 2018 Research and Development Ocrevus, Roche, multiple sclerosis, pharma

Roche has unveiled new five-year data from three Phase 3 open-label extension studies investigating the efficacy of Ocrevus (ocrelizumab) in …
38254130862_0f3fa01db3_z

New US trade policy may limit foreign investment into biotechs

October 11, 2018 Research and Development CIFUS, Trump, america, biotech, capital, foreign investment

The US Trump Administration have issued new rules, which will put foreign investment into companies involved in the development and …

Sequiris invest £40m into expansion of Liverpool plant creating 100 new jobs

October 11, 2018 Manufacturing and Production, Research and Development Jobs, Vaccine, investment, liverpool

The Liverpool-based vaccine-maker Sequiris is investing £40 million into the expansion of its operations in the Speke area of Liverpool. …
psm_v46_d168_mesial_view_of_the_human_brain

Increased funding and research could help address unmet mental health needs

October 10, 2018 Research and Development funding, global data, mental health, research

Unmet needs relating to mental health could be met through increasing funding and research, according to data analytics firm GlobalData. …

NICE recommends first new X-linked hypophosphataemia therapy in over 30 years

October 10, 2018 Research and Development, Sales and Marketing Crysvita, Kyowa Kirin International, NHS, NICE, X-linked hypophosphataemia, pharma

NICE has announced its evidence-based recommendation that Kyowa Kirin International’s Crysvita (burosumab) be made available on the NHS for the …

Sackler-owned Mundipharma acquires biosimilar firm Cinfa Biotech

October 10, 2018 Research and Development Mundipharma, biosimilar, cinfa biotech, sackler

In a bid to strengthen their biosimilar portfolio, the Cambridge based pain management company Mundipharma has acquired biosimilar development firm …
novartis_outside_1

Novartis’ sickle cell drug reduces vaso-occlusive crises by 35% at Phase 2

October 10, 2018 Research and Development Novartis, crizanlizumab, pharma, sickle cell disease

Novartis has presented new Phase 2 data for its humanised anti-P-selectin monoclonal antibody crizanlizumab in the treatment of sickle cell …
14012226029_debf038610_z

WHO voices concern over British immigration policies after researchers refused entry

October 10, 2018 Research and Development WHO, academia, immigration, research, universities

The World Health Organization (WHO) has expressed concern over the UK’s immigration polices, after a number of academics were refused …
The Gateway to Local Adoption Series

Latest content